Monday, November 9, 2026

USD/EUR Bearish Momentum: 0.97% Down In The Last 5 Sessions

ViaNews Editorial Team

December 18, 2023

USD/EUR Bearish Momentum: 0.97% Down In The Last 5 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.97% for the last 5 sessions. At 22:13 EST on Sunday, 17 December, USD/EUR (USDEUR) is $0.92.

USD/EUR's yearly highs and lows, it's 3.461% up from its 52-week low and 4.117% down from its 52-week high.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Eur/usd price analysis: bulls await a move beyond 1.1015 before placing fresh bets. According to FXStreet on Friday, 15 December, "In contrast, the Federal Reserve (Fed) indicated that rate cuts are likely next year and drag the US Dollar (USD) to over a four-month low during the Asian session, which, in turn, is seen acting as a tailwind for the EUR/USD pair.", "On the flip side, the 1.0945 region now seems to protect the immediate downside, below which the EUR/USD pair could slide back to test sub-1.0900 levels. "
  • According to FXStreet on Friday, 15 December, "Today, disappointing European PMI data have prevented EUR/USD from kicking on after breaking above 1.10 on Thursday and that is going to be a familiar pattern as long as the European economy struggles."
  • Eur/usd gathers strength near 1.1000 ahead of the eurozone US PMI data. According to FXStreet on Friday, 15 December, "The EUR/USD pair gains momentum near the 1.1000 mark during the early Asian session on Friday. ", "In response to the ECB's decision, the Euro (EUR) attracted some buyers and lifted the EUR/USD pair. "
  • According to FXStreet on Friday, 15 December, "The EUR/USD pair showed no immediate reaction to these comments and was last seen trading flat on the day at around 1.0990."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com